GLP-1 receptor agonist drugs, including Ozempic and Wegovy, promote earlier satiety to suppress appetite

Overview Debates Related claims Topics

Sam Tallent lost 120 pounds after quitting alcohol consumption and using the prescription medication Mounjaro

Parallel Bio received approval from the United States Food and Drug Administration to test drug toxicity on human organoids instead of live animal trials

Ignota Labs modifies the molecular structures of shelved drug candidates that failed clinical trials due to organ toxicity to advance them into stage-two trials

Prescription benefit managers frequently reimburse independent pharmacies at rates lower than the wholesale acquisition costs of medications

Sterile compounding requires specialized cleanroom facilities to prepare medications that are safe for injection

Standard commercial progesterone formulations often contain peanut oil as an inactive ingredient

Compounding pharmacies prepare customized medication formulations tailored to individual patient allergies and physiological needs

Excess body weight and obesity represent major modifiable risk factors for obstructive sleep apnea

President Barack Obama appointed former Monsanto attorney Michael Taylor to lead the food safety division at the Food and Drug Administration

Meaningful weight reduction reduces the apnea-hypopnea index in individuals whose obstructive sleep apnea is driven by excess adiposity

A 1970s United States federal law reclassified multiple cognitive and psychedelic compounds overnight under controlled substance schedules

Adderall is composed of a pharmaceutical mixture of four distinct amphetamine salts

Methamphetamine is approved by the United States Food and Drug Administration under the brand name Desoxyn for ADHD and obesity

The United States Food and Drug Administration banned the dietary supplement stimulant DMAA in 2013 due to cardiovascular risks

Modafinil is classified as a Schedule IV controlled substance under United States federal drug regulations

Selegiline, also known as Deprenyl, is an MAO inhibitor originally approved as a prescription drug for Parkinson's disease

The United States Food and Drug Administration removed picamilon from the dietary supplement market in 2015

The United States Food and Drug Administration banned ephedrine from dietary supplements in 2004

Ephedrine remains legally available behind pharmacy counters in the United States without a prescription for nasal congestion and asthma

Tianeptine is an antidepressant in Europe that binds to opioid receptors at elevated dosages